Trial Profile
A phase II clinical trial of MZ-004 for the treatment of coronary chronic total occlusions (CTOs)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Collagenase (Primary)
- Indications Arterial occlusive disorders
- Focus Adverse reactions; Therapeutic Use
- Acronyms TOSCA-5
- 09 Mar 2016 New trial record